Subscribe to this journal
Advanced Search
 array:22 [
  "pii" => "S2254887424001383"
  "issn" => "22548874"
  "doi" => "10.1016/j.rceng.2024.10.008"
  "estado" => "S5"
  "fechaPublicacion" => "2024-10-28"
  "aid" => "2246"
  "copyright" => "Elsevier Ltd. All rights reserved"
  "copyrightAnyo" => "2024"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "crp"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:17 [
    "pii" => "S2254887424001371"
    "issn" => "22548874"
    "doi" => "10.1016/j.rceng.2024.10.007"
    "estado" => "S5"
    "fechaPublicacion" => "2024-10-29"
    "aid" => "2245"
    "copyright" => "Elsevier Ltd"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
      "titulo" => "2024 Spanish Society of Internal Medicine &#40;SEMI&#41; recommendations for the management of cancer-associated venous thrombosis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Recomendaciones 2024 de la Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41; para el manejo de la trombosis venosa asociada al c&#225;ncer"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Aurora Villalobos, Reina Valle, Javier Pag&#225;n-Escribano, Mar&#237;a Ortiz, Pablo Demelo-Rodr&#237;guez, Carme Font"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Aurora"
              "apellidos" => "Villalobos"
            ]
            1 => array:2 [
              "nombre" => "Reina"
              "apellidos" => "Valle"
            ]
            2 => array:2 [
              "nombre" => "Javier"
              "apellidos" => "Pag&#225;n-Escribano"
            ]
            3 => array:2 [
              "nombre" => "Mar&#237;a"
              "apellidos" => "Ortiz"
            ]
            4 => array:2 [
              "nombre" => "Pablo"
              "apellidos" => "Demelo-Rodr&#237;guez"
            ]
            5 => array:2 [
              "nombre" => "Carme"
              "apellidos" => "Font"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001371?idApp=WRCEE"
    "url" => "/22548874/unassign/S2254887424001371/v1_202410291020/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "S2254887424001103"
    "issn" => "22548874"
    "doi" => "10.1016/j.rceng.2024.08.001"
    "estado" => "S200"
    "fechaPublicacion" => "2024-08-28"
    "aid" => "2233"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Soluble receptor for advanced glycation end-products positively correlated to kidney injury with coronary heart disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El receptor soluble para productos finales de glicaci&#243;n avanzada se correlacion&#243; positivamente con la lesi&#243;n renal con la enfermedad coronaria"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1825
              "Ancho" => 3341
              "Tamanyo" => 319191
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0015"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Correlation analysis between sRAGE and uACR in CHD patients &#40;A&#41;&#44; and ROC analysis of sRAGE&#44; UMA&#44; eGFR&#44; SCr&#44; UCr&#44; Albumin and BUN with uACR&#160;&#8805;&#160;30&#160;mg&#47;g in CHD patients &#40;B&#41;&#46;</p> <p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Each dot represents an individual patient&#46; BUN&#58; blood urea nitrogen&#59; CHD&#58; coronary heart disease&#59; eGFR&#58; estimated Glomerular Filtration Rate&#59; ROC&#58; receiver operating characteristic&#59; SCr&#58; serum creatinine&#59; sRAGE&#58; soluble receptor for advanced glycation end products&#59; uACR&#58; urinary albumin to creatinine ratio&#59; UCr&#58; urine creatinine&#59; UMA&#58; urine microalbumin&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lu Chen, Xiang-Jun Zeng, Xin-Ying Guo, Jian Liu, Feng-He Du, Cai-Xia Guo"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Lu"
              "apellidos" => "Chen"
            ]
            1 => array:2 [
              "nombre" => "Xiang-Jun"
              "apellidos" => "Zeng"
            ]
            2 => array:2 [
              "nombre" => "Xin-Ying"
              "apellidos" => "Guo"
            ]
            3 => array:2 [
              "nombre" => "Jian"
              "apellidos" => "Liu"
            ]
            4 => array:2 [
              "nombre" => "Feng-He"
              "apellidos" => "Du"
            ]
            5 => array:2 [
              "nombre" => "Cai-Xia"
              "apellidos" => "Guo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0014256524001498"
        "doi" => "10.1016/j.rce.2024.06.016"
        "estado" => "S200"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256524001498?idApp=WRCEE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001103?idApp=WRCEE"
    "url" => "/22548874/unassign/S2254887424001103/v1_202408280421/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Brief Original</span>"
    "titulo" => "Anti-NOR90 antibodies and their clinical significance&#58; a multicenter experience in southern Spain"
    "tieneTextoCompleto" => 0
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Javier Mart&#237;nez de Victoria Carazo, Daniel Fern&#225;ndez Reyes, Francisco Javier de la Hera Fern&#225;ndez, Trinidad Gonz&#225;lez CejudoNuria Navarrete Navarrete, Jos&#233; Lu&#237;s Callejas Rubio"
        "autores" => array:5 [
          0 => array:4 [
            "nombre" => "Javier Mart&#237;nez de Victoria"
            "apellidos" => "Carazo"
            "email" => array:1 [
              0 => "jmdvc94@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Daniel Fern&#225;ndez"
            "apellidos" => "Reyes"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Francisco Javier de la Hera"
            "apellidos" => "Fern&#225;ndez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Trinidad Gonz&#225;lez CejudoNuria Navarrete"
            "apellidos" => "Navarrete"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Jos&#233; Lu&#237;s Callejas"
            "apellidos" => "Rubio"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Unidad de Enfermedades Autoinmunes Sist&#233;micas&#44; Hospital Universitario Cl&#237;nico San Cecilio&#44; Granada&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Laboratorio de An&#225;lisis Cl&#237;nicos&#44; Secci&#243;n de Inmunolog&#237;a&#44; Hospital Universitario Cl&#237;nico San Cecilio&#44; Granada&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Unidad de Enfermedades Autoinmunes Sist&#233;micas&#44; Hospital Universitario Virgen de las Nieves&#44; Granada&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Anticuerpos anti-NOR90 y su significaci&#243;n cl&#237;nica&#58; experiencia multic&#233;ntrica en el sur de Espa&#241;a"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1899335"
          "palabras" => array:5 [
            0 => "Key words"
            1 => "systemic sclerosis"
            2 => "NOR-90"
            3 => "autoantibodies"
            4 => "interstitial pulmonary disease"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1899336"
          "palabras" => array:4 [
            0 => "esclerosis sist&#233;mica"
            1 => "NOR-90"
            2 => "autoanticuerpos"
            3 => "enfermedad pulmonar intersticial difusa"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Anti-NOR90 antibodies were initially described in patients with autoimmune diseases based on staining of a nucleolar region known as the nucleolar organizer region &#40;NOR&#41;&#46; This study aims to explore the clinical aspects of anti-NOR90 antibodies in patients with systemic autoimmune diseases&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Observational study of patients with positive anti-NOR90 antibodies using the EUROLINE Systemic Sclerosis profile &#40;IgG&#41; kit &#40;Euroimmun&#44; Germany&#41;&#46; Data on demographics&#44; comorbidities&#44; autoimmune diseases&#44; treatment&#44; and clinical manifestations were collected&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Fifteen Patients with positive anti-NOR90 antibodies were included&#46; Majority were female &#40;86&#46;7&#37;&#41;&#44; with median age of 54 years&#46; Most common clinical manifestations were Raynaud&#39;s phenomenon&#44; dryness&#44; and interstitial lung disease &#40;ILD&#41;&#46; Some patients had hematological or solid organ neoplasms&#46; EPID was prevalent&#44; with one case showing rapid progression requiring aggressive treatment&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discussion and conclusion</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">This study highlights the association between anti-NOR90 antibodies and systemic autoimmune diseases&#44; particularly SS and ES&#46; EPID was a notable feature&#44; suggesting its consideration in IPAF diagnosis for anti-NOR90 positive patients&#46; Further multicenter studies are needed for better understanding and detection methods optimization&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Introduction"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Methods"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Discussion and conclusion"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introducci&#243;n</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Los anticuerpos anti-NOR90 fueron descritos inicialmente en pacientes con enfermedades autoinmunes bas&#225;ndose en la tinci&#243;n de una regi&#243;n nucleolar conocida como regi&#243;n organizadora nucleolar &#40;NOR&#41;&#46; Este estudio tiene como objetivo explorar los aspectos cl&#237;nicos de los anticuerpos anti-NOR90 en pacientes con enfermedades autoinmunes sist&#233;micas&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">M&#233;todos</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Estudio observacional de pacientes con anticuerpos anti-NOR90 positivos mediante el kit EUROLINE Systemic Sclerosis profile &#40;IgG&#41; &#40;Euroimmun&#44; Alemania&#41;&#46; Se recopilaron datos demogr&#225;ficos&#44; comorbilidades&#44; enfermedades autoinmunes&#44; tratamiento y manifestaciones cl&#237;nicas&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Se incluyeron quince pacientes con anticuerpos anti-NOR90 positivos&#46; La mayor&#237;a eran mujeres &#40;86&#46;7&#37;&#41; con una mediana de edad de 54 a&#241;os&#46; Las manifestaciones cl&#237;nicas m&#225;s comunes fueron el fen&#243;meno de Raynaud&#44; la sequedad y la enfermedad pulmonar intersticial &#40;EPI&#41;&#46; Algunos pacientes presentaban neoplasias hematol&#243;gicas u org&#225;nicas s&#243;lidas&#46; La EPI fue prevalente&#44; con un caso mostrando progresi&#243;n r&#225;pida que requiri&#243; tratamiento agresivo&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Discusi&#243;n y conclusiones</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Este estudio destaca la asociaci&#243;n entre los anticuerpos anti-NOR90 y las enfermedades autoinmunes sist&#233;micas&#44; particularmente el SS y la ES&#46; La EPI fue una caracter&#237;stica notable&#44; sugiriendo su consideraci&#243;n en el diagn&#243;stico de la neumopat&#237;a intersticial autoinmune &#40;IPAF&#41; en pacientes con anticuerpos anti-NOR90 positivos&#46; Se necesitan estudios multic&#233;ntricos adicionales para una mejor comprensi&#243;n y optimizaci&#243;n de los m&#233;todos de detecci&#243;n&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Introducci&#243;n"
          ]
          1 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "M&#233;todos"
          ]
          2 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Discusi&#243;n y conclusiones"
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/22548874/unassign/S2254887424001383/v1_202410280401/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/22548874/unassign/S2254887424001383/v1_202410280401/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001383?idApp=WRCEE"
]
Share
Current Issue
Journal Information
Export reference
Share
Share
Print
Download PDF
More article options
Statistics
Brief Original
DOI: 10.1016/j.rceng.2024.10.008
Pre-proof, online 28 October 2024
Anti-NOR90 antibodies and their clinical significance: a multicenter experience in southern Spain
Anticuerpos anti-NOR90 y su significación clínica: experiencia multicéntrica en el sur de España
Download PDF
Javier Martínez de Victoria Carazoa,
Corresponding author
jmdvc94@gmail.com

Corresponding author.
, Daniel Fernández Reyesa, Francisco Javier de la Hera Fernándeza, Trinidad González CejudoNuria Navarrete Navarreteb,c, José Luís Callejas Rubioa
a Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Clínico San Cecilio, Granada, Spain
b Laboratorio de Análisis Clínicos, Sección de Inmunología, Hospital Universitario Clínico San Cecilio, Granada, Spain
c Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Virgen de las Nieves, Granada, Spain

Purchase article

For the purchase of this article it is necessary to fill in the following form:

Afganistan
Albania
Alemania
Andorra
Angola
Anguilla
Antartica
Antigua and barbuda
Antillas holandesas
Arabia saudita
Argelia
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgica
Belice
Benin
Bermudas/antillas britanicas
Bhutan
Bolivia
Bosnia y herzegowina
Botswana
Brasil
Brunei darussalam
Bulgaria
Burkina faso
Burundi
Cabo verde
Camboya
Camerun
Canada
Chad
Chile
China
Chipre
Colombia
Comoros
Corea
Costa rica
Cote d´ivoire
Croacia
Cuba
Dinamarca
Djibouti
Dominica
East timor
Ecuador
Egipto
El salvador
Emiratos arabes unidos
Eritrea
Escocia
Eslovaquia
Eslovenia
España
Estados federados de micronesia
Estados unidos
Estonia
Etiopia
Fiji
Filipinas
Finlandia
Francia
Gabon
Gambia
Georgia
Ghana
Gibraltar
Grecia
Grenada
Groenlandia
Guadalupe
Guam
Guatemala
Guayana britanica
Guinea
Guinea ecuatorial
Guinea francesa
Guinea-bissau
Haiti
Holanda
Honduras
Hong kong
Hungria
India
Indonesia
Irak
Iran
Irlanda
Isla bouvet
Isla cocos (keeling)
Isla cook
Isla mauricio
Isla navidad
Isla norfolk
Islandia
Islas caiman
Islas falkland (malvinas)
Islas faroe
Islas georgia del sur y sandwich
Islas heard and mc donald
Islas marshall
Islas northern mariana
Islas salomon
Islas svalbard and jan mayen
Islas turks and caicos
Islas united states minor outlyi
Islas virgenes (britanicas)
Islas virgenes (u.s.a.)
Islas wallis and futuna
Israel
Italia
Jamaica
Japon
Jordania
Kazakhstan
Kenia
Kiribati
Kuwait
Kyrgyzstan
Lesoto
Letonia
Libano
Liberia
Libia arab jamahiriya
Liechtenstein
Lituania
Luxemburgo
Macao
Macedonia
Madagascar
Malasia
Malawi
Maldives
Mali
Malta
Marruecos
Martinica
Mauritania
Mayotte
Mexico
Monaco
Mongolia
Monserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Nicaragua
Niger
Nigeria
Niue
Noruega
Nueva caledonia
Nueva zelanda
Oman
Pakistan
Palau
Panama
Papua new guinea
Paraguay
Peru
Pitcairn
Polinesia francesa
Polonia
Portugal
Posesiones gran bretaña
Posesiones u.s.a.
Puerto rico
Qatar
Reino unido
Republica checa
Republica de africa central
Republica de cabo verde
Republica de congo
Republica de corea
Republica de moldova
Republica democratica de laos
Republica democratica del congo
Republica dominicana
Reunion
Ruanda
Rumania
Rusia
Sahara occidental
Saint kitts and nevis
Samoa
Samoa americana
San marino
San tomas y principe
San vincent and the grenadines
Santa lucia
Senegal
Serbia
Seychelles
Sierra leona
Singapur
Siria
Somalia
Sri lanka
St. helena
St. pierre and miquelon
Sudafrica
Sudan
Suecia
Suiza
Surinam
Swaziland
Tailandia
Taiwan republica de china
Tajikistan
Tanzania
Territorio de indias britanicas
Togo
Tokelau
Tonga
Trinidad and tobago
Tunisia
Turkmenistan
Turquia
Tuvalu
Ucrania
Uganda
Uruguay
Uzbekistan
Vanuatu
Vaticano
Venezuela
Vietnam
Yemen
Yugoslavia
Zambia
Zimbawe
Lebanon
Paises bajos
A coruña
Alava
Albacete
Alicante
Almeria
Asturias
Avila
Badajoz
Balears
Barcelona
Bizkaia
Burgos
Caceres
Cadiz
Cantabria
Castellon
Ceuta
Ciudad real
Cordoba
Cuenca
Girona
Granada
Guadalajara
Guipuzcoa
Huelva
Huesca
Jaen
La rioja
Las palmas
Leon
Lleida
Lugo
Madrid
Malaga
Melilla
Murcia
Navarra
Ourense
Palencia
Pontevedra
Salamanca
Segovia
Sevilla
Soria
Tarragona
Tenerife
Teruel
Toledo
Valencia
Valladolid
Zamora
Zaragoza
-- Not applicable --
I accept to receive information about Elsevier's special products and promotions by email
I accept to receive information about products and special promotions from Elsevier partners by email
I have read and understand the Privacy Policy and Terms and conditions and agree to be bound by all of its terms.
* Required fields
In addition to temporary access to the article, it will be sent by email.
Customer Support
Phone
Calls from Spain
932 415 960
Calls from abroad
+34 932 415 960
Hours from 9 a.m. to 6 p.m. except the months of July and August, which will be from 9 am to 3 pm.

Subscribe to our newsletter

Highlighted articles
Publish in
Revista Clínica Española
Free access articles
The value of multi-modal ultrasound in the assessment of...
Rev Clin Esp. 2024;224:437-44
Adverse cardiovascular, obstetric and perinatal events...
Rev Clin Esp. 2024;224:337-45
How to detect non-institutionalized older patients at risk...
Rev Clin Esp. 2024;224:217-24
Revista Clínica Española (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Revista Clínica Española (English Edition)